These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6111621)

  • 1. [Pharmacologic agents for preventing and treating motion sickness].
    Shashkov VS; Sabaev VV
    Kosm Biol Aviakosm Med; 1981; 15(1):9-18. PubMed ID: 6111621
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic considerations on kinetoses].
    Ferrotti A
    Minerva Med; 1970 Apr; 61(28):1408-16. PubMed ID: 4396663
    [No Abstract]   [Full Text] [Related]  

  • 3. [Motion sickness and its treatment (author's transl)].
    Petrin A
    Schweiz Rundsch Med Prax; 1974 Jan; 63(3):79-81. PubMed ID: 4153225
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs for relief of nausea and vomiting.
    Med Lett Drugs Ther; 1974 May; 16(11):46-8. PubMed ID: 4151675
    [No Abstract]   [Full Text] [Related]  

  • 5. Theory of antimotion sickness drug mechanisms.
    Wood CD; Graybiel A
    Aerosp Med; 1972 Mar; 43(3):249-52. PubMed ID: 4402925
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions.
    Wood CD; Graybiel A
    Aerosp Med; 1968 Dec; 39(12):1341-4. PubMed ID: 4881887
    [No Abstract]   [Full Text] [Related]  

  • 7. Antivertigo and antimotion sickness drugs.
    Digregorio GJ
    Am Fam Physician; 1978 Dec; 18(6):130-2. PubMed ID: 32758
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems in the drug prevention of the seasickness syndrome (motion sickness)].
    Shashkov VS; Sabaev VV; Il'ina SL; Galle RR
    Farmakol Toksikol; 1987; 50(3):5-20. PubMed ID: 2886362
    [No Abstract]   [Full Text] [Related]  

  • 9. [Model of motion sickness in dogs for assessing the effectiveness of pharmacological substances].
    Radkevich LA
    Kosm Biol Aviakosm Med; 1977; 11(6):50-3. PubMed ID: 22775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevention of motion sickness in orbital flight.
    Graybiel A
    Life Sci Space Res; 1976; 14():109-18. PubMed ID: 11977268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-nauseant drugs.
    Milton-Thompson GJ
    Practitioner; 1979 Oct; 223(1336):516-9. PubMed ID: 42893
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimotion sickness drug efficacy.
    Wood CD; Cramer DB; Graybiel A
    Otolaryngol Head Neck Surg; 1981; 89(6):1041-4. PubMed ID: 6121316
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigation of anti-motion sickness drugs in the squirrel monkey.
    Cheung BS; Money KE; Kohl RL; Kinter LB
    J Clin Pharmacol; 1992 Feb; 32(2):163-75. PubMed ID: 1613127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimotion sickness and antiemetic drugs.
    Wood CD
    Drugs; 1979 Jun; 17(6):471-9. PubMed ID: 467277
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological interventions for motion sickness: cardiovascular effects.
    Sunahara FA; Farewell J; Mintz L; Johnson WH
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A270-6. PubMed ID: 3499896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of motion sickness.
    Lucot JB
    J Vestib Res; 1998; 8(1):61-6. PubMed ID: 9416591
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug therapy. Anticholinergics.
    Greenblatt DJ; Shader RI
    N Engl J Med; 1973 Jun; 288(23):1215-9. PubMed ID: 4144756
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
    Graybiel A; Knepton J; Shaw J
    Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anti-motion sickness drugs by body responses to labyrinthine stimulation.
    Sugano H; Tominaga H
    Agressologie; 1977; 18 Spec No():63-7. PubMed ID: 19980
    [No Abstract]   [Full Text] [Related]  

  • 20. Vertigo and motion sickness. Part II: Pharmacologic treatment.
    Zajonc TP; Roland PS
    Ear Nose Throat J; 2006 Jan; 85(1):25-35. PubMed ID: 16509240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.